Matches in SemOpenAlex for { <https://semopenalex.org/work/W2171186104> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2171186104 endingPage "336" @default.
- W2171186104 startingPage "335" @default.
- W2171186104 abstract "Bisphosphonates are increasingly used to treat metabolic bone disease and as prophylaxis against metastatic bone cancer.1 2 Zoledronic acid is a new intravenous bisphosphonate licensed to treat hypercalcaemia of malignancy, but it has been used off licence as prophylaxis for metastatic cancer, bone pain, treatment of osteoporosis, and Paget's disease of the bone. Zoledronic acid is 100 to 1000 times more potent than disodium pamidronate or oral alendronic acid, risedronate sodium, sodium clodronate, or disodium etidronate. A randomised controlled trial found that zoledronic acid is more effective than disodium pamidronate in treating hypercalcaemia of malignancy.3 Zoledronic acid does not cause the gastrointestinal side effects associated with oral bisphosphonates, but increased potency carries a higher risk of hypocalcaemia. We have recent experience of patients becoming hypocalcaemic after doctors gave intravenous bisphosphonates.### Case 1A 49 year old man with transitional cell carcinoma of the bladder received chemotherapy with cisplatin, methotrexate, and vinblastine after resection of a tumour. His prechemotherapy adjusted calcium was normal. Despite four cycles of chemotherapy every two weeks he had bone pain due to metastases. Doctors gave him 4 mg of zoledronic acid and intravenous diamorphine after diclofenac sodium and co-proxamol failed to relieve his symptoms. His adjusted calcium six days before being given zoledronic acid was low (table).View this table:Serum analyte concentrations in patents given bisphosphonatesThree days after being given intravenous zoledronic acid, he had tetanic spasms and paraesthesia. Trousseau's sign was positive and an electrocardiogram showed a long QT interval—474 ms (RR < 440 ms). His adjusted calcium …" @default.
- W2171186104 created "2016-06-24" @default.
- W2171186104 creator A5015200917 @default.
- W2171186104 creator A5041050064 @default.
- W2171186104 creator A5071807128 @default.
- W2171186104 date "2004-02-05" @default.
- W2171186104 modified "2023-10-14" @default.
- W2171186104 title "Severe hypocalcaemia after being given intravenous bisphosphonate" @default.
- W2171186104 cites W1951349736 @default.
- W2171186104 cites W1971432874 @default.
- W2171186104 cites W1988150563 @default.
- W2171186104 cites W1990481144 @default.
- W2171186104 cites W1990783720 @default.
- W2171186104 cites W2048665599 @default.
- W2171186104 cites W2052740066 @default.
- W2171186104 cites W2138220544 @default.
- W2171186104 cites W2266457946 @default.
- W2171186104 cites W2937258708 @default.
- W2171186104 cites W94650443 @default.
- W2171186104 doi "https://doi.org/10.1136/bmj.328.7435.335" @default.
- W2171186104 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/338107" @default.
- W2171186104 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14764499" @default.
- W2171186104 hasPublicationYear "2004" @default.
- W2171186104 type Work @default.
- W2171186104 sameAs 2171186104 @default.
- W2171186104 citedByCount "89" @default.
- W2171186104 countsByYear W21711861042012 @default.
- W2171186104 countsByYear W21711861042013 @default.
- W2171186104 countsByYear W21711861042014 @default.
- W2171186104 countsByYear W21711861042015 @default.
- W2171186104 countsByYear W21711861042016 @default.
- W2171186104 countsByYear W21711861042017 @default.
- W2171186104 countsByYear W21711861042018 @default.
- W2171186104 countsByYear W21711861042019 @default.
- W2171186104 countsByYear W21711861042020 @default.
- W2171186104 countsByYear W21711861042021 @default.
- W2171186104 countsByYear W21711861042022 @default.
- W2171186104 countsByYear W21711861042023 @default.
- W2171186104 crossrefType "journal-article" @default.
- W2171186104 hasAuthorship W2171186104A5015200917 @default.
- W2171186104 hasAuthorship W2171186104A5041050064 @default.
- W2171186104 hasAuthorship W2171186104A5071807128 @default.
- W2171186104 hasBestOaLocation W21711861042 @default.
- W2171186104 hasConcept C126322002 @default.
- W2171186104 hasConcept C177713679 @default.
- W2171186104 hasConcept C2776541429 @default.
- W2171186104 hasConcept C2777251235 @default.
- W2171186104 hasConcept C2778812048 @default.
- W2171186104 hasConcept C41008148 @default.
- W2171186104 hasConcept C519063684 @default.
- W2171186104 hasConcept C71924100 @default.
- W2171186104 hasConceptScore W2171186104C126322002 @default.
- W2171186104 hasConceptScore W2171186104C177713679 @default.
- W2171186104 hasConceptScore W2171186104C2776541429 @default.
- W2171186104 hasConceptScore W2171186104C2777251235 @default.
- W2171186104 hasConceptScore W2171186104C2778812048 @default.
- W2171186104 hasConceptScore W2171186104C41008148 @default.
- W2171186104 hasConceptScore W2171186104C519063684 @default.
- W2171186104 hasConceptScore W2171186104C71924100 @default.
- W2171186104 hasIssue "7435" @default.
- W2171186104 hasLocation W21711861041 @default.
- W2171186104 hasLocation W21711861042 @default.
- W2171186104 hasLocation W21711861043 @default.
- W2171186104 hasLocation W21711861044 @default.
- W2171186104 hasOpenAccess W2171186104 @default.
- W2171186104 hasPrimaryLocation W21711861041 @default.
- W2171186104 hasRelatedWork W1506200166 @default.
- W2171186104 hasRelatedWork W1981696963 @default.
- W2171186104 hasRelatedWork W1995515455 @default.
- W2171186104 hasRelatedWork W2080531066 @default.
- W2171186104 hasRelatedWork W2106744421 @default.
- W2171186104 hasRelatedWork W2748952813 @default.
- W2171186104 hasRelatedWork W2899084033 @default.
- W2171186104 hasRelatedWork W3031052312 @default.
- W2171186104 hasRelatedWork W3032375762 @default.
- W2171186104 hasRelatedWork W3108674512 @default.
- W2171186104 hasVolume "328" @default.
- W2171186104 isParatext "false" @default.
- W2171186104 isRetracted "false" @default.
- W2171186104 magId "2171186104" @default.
- W2171186104 workType "article" @default.